Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

ABBOTT IRELAND

US

Last updated May 24, 2026

What ABBOTT IRELAND makes

The company manufactures in vitro diagnostic (IVD) kits and systems for measuring thyroid hormones—including free thyroxine (FT4), total thyroxine (TT4), total triiodothyronine (TT3), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH)—using chemiluminescent immunoassay technology. It also produces kits for albumin, progesterone, and total aspartate aminotransferase (AST) assays, primarily using spectrophotometry. These products are designed for laboratory use in automated platforms like ARCHITECT and Alinity.

The diagnostic kits fall under FDA device classes I and II, with regulatory submissions including 510(k) clearances and Unique Device Identifier (UDI) listings. The company’s products are authorised for use in the United States, where the manufacturer is based.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Abbott Ireland manufacture?

Abbott Ireland manufactures in vitro diagnostic (IVD) kits and automated systems for laboratory testing. These include chemiluminescent immunoassay kits for thyroid hormones—such as free thyroxine (FT4), total thyroxine (TT4), total triiodothyronine (TT3), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH)—as well as spectrophotometry-based kits for albumin, progesterone, and total aspartate aminotransferase (AST). The devices are designed for use in automated platforms like ARCHITECT and Alinity.

Where is Abbott Ireland based, and what is its primary market focus?

Abbott Ireland is based in the United States. Its primary focus is on developing and manufacturing in vitro diagnostic (IVD) devices authorised for use in the U.S. market. The company specialises in thyroid hormone assays and other laboratory tests, catering to clinical and diagnostic needs in healthcare settings.

Which regulatory registries list Abbott Ireland’s devices?

Abbott Ireland’s devices are listed in the FDA’s 510(k) clearance registry and the Unique Device Identifier (UDI) database. These registries document regulatory submissions and authorisations required for IVD devices in the United States, ensuring compliance with FDA requirements.

How are Abbott Ireland’s devices classified under FDA regulations?

Abbott Ireland’s IVD devices fall under FDA device classes I and II. Class I devices generally pose minimal risk and may require less stringent regulatory oversight, while Class II devices involve moderate risk and require special controls to ensure safety and effectiveness. The classification is determined based on the device’s intended use and potential health impact.

What technologies are used in Abbott Ireland’s diagnostic kits?

Abbott Ireland’s diagnostic kits primarily utilise chemiluminescent immunoassay technology for thyroid hormone assays (e.g., FT4, TT4, FT3, TT3, TSH) and spectrophotometry for tests like albumin, progesterone, and AST. These technologies enable precise and automated measurements in clinical laboratory settings, improving diagnostic accuracy and efficiency.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
xx.xx
LinkedIn
—
Facebook
—
Phone
+1(877)422-2688
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
989964119

Catalogue (240)

Page 2 of 5
DeviceModel / ReferenceRegistriesClassStatus
Architect 08L9224
FDA UDI
Class IActive
Alinity 07P9120
FDA UDI
Class IActive
Architect 7K61-37
FDA UDI
Class IIActive
Alinity 04U2620
FDA UDI
Class IActive
Architect 7K66-25
FDA UDI
Class IActive
Alinity 07P6930
FDA UDI
Class IIActive
Architect 7K62-10
FDA UDI
Class IIActive
Architect 02R9825
FDA UDI
Class IIActive
Alinity 04R9924
FDA UDI
Class IIActive
Architect 1P74-12
FDA UDI
Class IIActive
Architect 04S9030
FDA UDI
Class IIActive
Alinity 07P7020
FDA UDI
Class IIActive
Architect 7K77-10
FDA UDI
Class IIActive
Alinity 07P9101
FDA UDI
Class IIActive
Architect 02K9824
FDA UDI
Class IActive
Architect 7K77-01
FDA UDI
Class IIActive
Architect 5P02-30
FDA UDI
Class IIActive
Architect 7K76-25
FDA UDI
Class IActive
Alinity 07P9530
FDA UDI
Class IIActive
Alinity 08P1824
FDA UDI
Class IActive
Architect 07K6312
FDA UDI
Class IActive
Architect 7K75-35
FDA UDI
Class IActive
Architect 7K75-01
FDA UDI
Class IIActive
Alinity 07P9130
FDA UDI
Class IActive
Architect 2P40-35
FDA UDI
Class IActive
Alinity 04U0920
FDA UDI
Class IActive
Alinity 04T8620
FDA UDI
Class IIActive
Architect 5P02-12
FDA UDI
Class IIActive
Architect 07K6402
FDA UDI
Class IIActive
Architect 7K62-01
FDA UDI
Class IActive
Alinity 09P4724
FDA UDI
Class IIActive
Alinity 07P5101
FDA UDI
Class IIActive
Alinity 07P9430
FDA UDI
Class IIActive
Alinity 04T8130
FDA UDI
Class IIActive
Alinity 08P1431
FDA UDI
Class IIActive
Alinity 04T9630
FDA UDI
Class IActive
Architect 7K59-01
FDA UDI
Class IIActive
Architect 04S8830
FDA UDI
Class IActive
Architect 7K66-01
FDA UDI
Class IActive
Architect 03P6834
FDA UDI
Class IActive
Alinity 04T9820
FDA UDI
Class IActive
Architect 04T3020
FDA UDI
Class IActive
Alinity 04U0930
FDA UDI
Class IActive
Architect 7K72-25
FDA UDI
Class IActive
Architect 09D9624
FDA UDI
Class IIActive
Architect 04T0030
FDA UDI
Class IActive
Architect 02R9835
FDA UDI
Class IIActive
Alinity 07P4810
FDA UDI
Class IActive
Architect 7K66-10
FDA UDI
Class IActive
Alinity 04T8230
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Abbott Ireland SLIGO · IE FEI 3008344661